POLICY / ELIGIBILITY
Purchase Eligibility Policy
Effective August 16, 2026 · Current release
Independent account and product review
Transaction eligibility is determined separately for each buyer, product, lot, destination, and channel. Catalog presence or RFQ submission does not itself authorize a transaction.
No automatic approval
Form submission, account review, supplier evidence, successful testing, a QR route, catalog presence, a competitor sale, or prior order does not by itself authorize a transaction.
Product decisions
Product availability is limited to the payment methods and destinations supported by our current review. Missing, expired or withdrawn decisions prevent payment access and shipment, even if a lot is in stock. Payment-provider acceptance does not establish FDA approval or replace applicable legal requirements.
Reorders
Returning researchers may reference their previous verification. We reuse supporting identity and research records when they remain valid, and check the new order’s research use, products, stock and delivery details. We request updated information when needed.